Alcohol-use disorders (prevention): consultation on the evidence (19th May 2009)
NICE was asked by the Department of Health (DH) to develop public health programme guidance on Alcohol use disorders in adults and young people: prevention and early identification. Registered stakeholders are now invited to comment on the assembled evidence. Closing date for comments is 17th June 2009.
Consultation
Prevention of type 2 diabetes: preventing pre-diabetes - draft scope consultation (20th May 2009)
NICE is developing public health programme guidance on the prevention of type 2 diabetes: preventing pre-diabetes among high-risk groups. Registered stakeholders are invited to comment on the draft scope. Closing date for comments is 18th June 2009.
Consultation
Hepatitis B - tenofovir disoproxil fumarate: final appraisal determination (26th May 2009)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Tenofovir disoproxil fumarate for the treatment of hepatitis B and submitted it to the Institute.
The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. Closing date for comments is 9th June 2009.
FAD
NICE was asked by the Department of Health (DH) to develop public health programme guidance on Alcohol use disorders in adults and young people: prevention and early identification. Registered stakeholders are now invited to comment on the assembled evidence. Closing date for comments is 17th June 2009.
Consultation
Prevention of type 2 diabetes: preventing pre-diabetes - draft scope consultation (20th May 2009)
NICE is developing public health programme guidance on the prevention of type 2 diabetes: preventing pre-diabetes among high-risk groups. Registered stakeholders are invited to comment on the draft scope. Closing date for comments is 18th June 2009.
Consultation
Hepatitis B - tenofovir disoproxil fumarate: final appraisal determination (26th May 2009)
After considering the feedback from consultation, the Appraisal Committee has prepared a Final Appraisal Determination (FAD) on Tenofovir disoproxil fumarate for the treatment of hepatitis B and submitted it to the Institute.
The FAD has been sent to the formal consultees for this appraisal who have 15 working days to consider whether they wish to appeal against it. Subject to any appeal by consultees, the FAD may be used as the basis for the Institute's guidance on the use of the appraised technology in the NHS in England and Wales. Closing date for comments is 9th June 2009.
FAD
Recognition and assessment of coeliac disease - Clinical Guideline CG86 (27th May 2009)
This guideline offers best practice advice on the recognition and assessment of coeliac disease and the care of children and adults who are undergoing the diagnostic process for coeliac disease.
Guideline
The acute management of patients with chronic (longer than 6 weeks) non-specific low back pain - Clinical Guideline CG88 (27th May 2009)
This guideline is about the care and treatment that people who have persistent non-specific low back pain can expect from the NHS in England and Wales to help them manage their pain.
Guideline
Type 2 diabetes - newer agents for blood glucose control in type 2 diabetes - Clinical Guideline CG87 (27th May 2009)
NICE clinical guideline 87 partially updates NICE clinical guideline 66 and replaces it. This guidance was developed by the National Collaborating Centre for Chronic Conditions. Details of the methods and evidence used to develop the recommendations are in the full guideline for CG66. The recommendations on DPP-4 inhibitors (sitagliptin, vildagliptin), thiazolidinediones (pioglitazone, rosiglitazone), exenatide and insulin were developed by the Centre for Clinical Practice at NICE. Details of the methods and evidence used to develop these recommendations are in the short guideline for CG87.
Guideline
Percutaneous endoscopic laser lumbar discectomy - Interventional Procedure Guidance IPG300 (27th May 2009)
Symptomatic thoracic disc herniation is when one of the discs in the bottom of the back which act as cushions between the bones bursts and pushes against the spinal cord or nerve roots that run through the backbone, causing: pain in the neck or back, weakness and numbness in the arms or legs, or bladder problems.
The aim of a percutaneous endoscopic laser discectomy is to remove the part of the disc that is pushing against the spinal cord or nerve root. A small cut is made in the skin and special equipment including a laser is used to heat and destroy some of the disc and remove the part that is sticking out to relieve pressure on the spinal cord or nerve root.
Guideline
Percutaneous laser revascularisation for refractory angina pectoris - Interventional Procedure Guidance IPG302 (27th May 2009)
Patients with refractory angina pectoris have chest pain (because of insufficient oxygen delivery to their heart muscle) that cannot be controlled by optimal medical or surgical management. Percutaneous laser revascularisation involves insertion of a catheter into major vessels of the groin, which is advanced to the heart, to drill holes on the heart muscle using a laser beam. The aim is to enable blood flow from the heart chambers into the heart muscle, to relieve myocardial ischaemia and reduce chest pain.
Guideline
Tenotomy of horizontal eye muscles for nystagmus (with reattachment at their original insertions) - Interventional Procedure Guidance IPG299 (27th May 2009)
Nystagmus is the involuntary movement of the eyes (most commonly from side to side) and is usually associated with impaired vision. Tenotomy involves cutting the horizontal muscles of the eye (which move the eye from side to side) and reattaching them at the same place. The aim of the procedure is to improve vision.
Guideline
Transmyocardial laser revascularisation for refractory angina pectoris - Interventional Procedure Guidance IPG301 (27th May 2009)
Patients with refractory angina pectoris have chest pain (because of insufficient oxygen delivery to their heart muscle) that cannot be controlled by optimal medical or surgical management. Transmyocardial laser revascularisation involves open heart surgery to drill holes on the heart muscle using a laser beam, with the aim of enabling blood flow from the heart chambers into the heart muscle, to relieve myocardial ischaemia and reduce chest pain.
Guideline
This guideline offers best practice advice on the recognition and assessment of coeliac disease and the care of children and adults who are undergoing the diagnostic process for coeliac disease.
Guideline
The acute management of patients with chronic (longer than 6 weeks) non-specific low back pain - Clinical Guideline CG88 (27th May 2009)
This guideline is about the care and treatment that people who have persistent non-specific low back pain can expect from the NHS in England and Wales to help them manage their pain.
Guideline
Type 2 diabetes - newer agents for blood glucose control in type 2 diabetes - Clinical Guideline CG87 (27th May 2009)
NICE clinical guideline 87 partially updates NICE clinical guideline 66 and replaces it. This guidance was developed by the National Collaborating Centre for Chronic Conditions. Details of the methods and evidence used to develop the recommendations are in the full guideline for CG66. The recommendations on DPP-4 inhibitors (sitagliptin, vildagliptin), thiazolidinediones (pioglitazone, rosiglitazone), exenatide and insulin were developed by the Centre for Clinical Practice at NICE. Details of the methods and evidence used to develop these recommendations are in the short guideline for CG87.
Guideline
Percutaneous endoscopic laser lumbar discectomy - Interventional Procedure Guidance IPG300 (27th May 2009)
Symptomatic thoracic disc herniation is when one of the discs in the bottom of the back which act as cushions between the bones bursts and pushes against the spinal cord or nerve roots that run through the backbone, causing: pain in the neck or back, weakness and numbness in the arms or legs, or bladder problems.
The aim of a percutaneous endoscopic laser discectomy is to remove the part of the disc that is pushing against the spinal cord or nerve root. A small cut is made in the skin and special equipment including a laser is used to heat and destroy some of the disc and remove the part that is sticking out to relieve pressure on the spinal cord or nerve root.
Guideline
Percutaneous laser revascularisation for refractory angina pectoris - Interventional Procedure Guidance IPG302 (27th May 2009)
Patients with refractory angina pectoris have chest pain (because of insufficient oxygen delivery to their heart muscle) that cannot be controlled by optimal medical or surgical management. Percutaneous laser revascularisation involves insertion of a catheter into major vessels of the groin, which is advanced to the heart, to drill holes on the heart muscle using a laser beam. The aim is to enable blood flow from the heart chambers into the heart muscle, to relieve myocardial ischaemia and reduce chest pain.
Guideline
Tenotomy of horizontal eye muscles for nystagmus (with reattachment at their original insertions) - Interventional Procedure Guidance IPG299 (27th May 2009)
Nystagmus is the involuntary movement of the eyes (most commonly from side to side) and is usually associated with impaired vision. Tenotomy involves cutting the horizontal muscles of the eye (which move the eye from side to side) and reattaching them at the same place. The aim of the procedure is to improve vision.
Guideline
Transmyocardial laser revascularisation for refractory angina pectoris - Interventional Procedure Guidance IPG301 (27th May 2009)
Patients with refractory angina pectoris have chest pain (because of insufficient oxygen delivery to their heart muscle) that cannot be controlled by optimal medical or surgical management. Transmyocardial laser revascularisation involves open heart surgery to drill holes on the heart muscle using a laser beam, with the aim of enabling blood flow from the heart chambers into the heart muscle, to relieve myocardial ischaemia and reduce chest pain.
Guideline
No comments:
Post a Comment